AKT1 and metabolic disease: The mechanisms include (1) direct antioxidant activity alleviating oxidative stress; (2) regulation of the PI3K/Akt/NF-κB signaling pathway to suppress inflammatory responses; and (3) improvement of hepatic lipid metabolism disorders.